Research Projects & Grants

For Profit Organization

• CYTB323J12201: A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients Suffering with active, refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN), Role: Investigator, Novartis Pharmaceuticals Corporation, (08/2025 - 08/2026) Status: Approved

Internal

• Cardiovascular risk management in lupus nephritis and IgA nephropathy patients, Role: Investigator, LLU Dept. of Medicine, (03/2023) Status: Approved
• Toe-brachial and ankle-brachial index and angiographically determined lower extremity arterial disease in patients with end-stage kidney disease on dialysis therapy and the respective association with subsequent amputation, Role: Investigator, LLU Dept. of Medicine, (07/2022) Status: Approved
• Gender and Socioeconomic Disparities in Cardiovascular Events Among Patients with Nephrotic Syndrome, Role: Investigator, LLU Dept. of Medicine, (03/2025) Status: Approved
• Personalized AI-Powered Education for Rare Glomerular Diseases and Polycystic Kidney Disease, Role: Investigator, LLU Dept. of Medicine, (02/2025) Status: Approved
• Barriers to Plant-Based Dieting in Chronic Kidney Disease Patients, Role: Investigator, LLU Dept. of Medicine, (08/2024 - 08/2025) Status: Approved